HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on MediWound (NASDAQ:MDWD) and maintained a price target of $28.
October 11, 2024 | 10:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on MediWound and maintained a price target of $28, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $28 price target by HC Wainwright & Co. suggests positive sentiment and confidence in MediWound's future performance. This could lead to increased investor interest and a potential rise in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100